McEachin, Joyce Lead Bipartisan Group Of Lawmakers In Calling For Broad Therapeutics For COVID-19 Variants
September 30, 2022
September 30, 2022
WASHINGTON, Sept. 30 -- Rep. A. Donald McEachin, D-Virginia, issued the following news release and letter on Sept. 29, 2022:
Representatives A. Donald McEachin (D-VA-04) and John Joyce, M.D. (R-PA-13) led a bipartisan group of 12 Members of Congress in urging Food and Drug Administration (FDA) Commissioner Robert M. Califf, M.D. to ensure there is a broad toolkit of available therapeutics to manage emerging COVID-19 variants.
Due to the rise of Delta and Omicron variant . . .
Representatives A. Donald McEachin (D-VA-04) and John Joyce, M.D. (R-PA-13) led a bipartisan group of 12 Members of Congress in urging Food and Drug Administration (FDA) Commissioner Robert M. Califf, M.D. to ensure there is a broad toolkit of available therapeutics to manage emerging COVID-19 variants.
Due to the rise of Delta and Omicron variant . . .